EYPT
Eyepoint Pharmaceuticals Inc
3.60$
-0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +0.0% | -42.3% | +0.0% | +283.7% | +1.8% | +25.7% | +187.2% | -31.5% | +96.9% | +17.8% | -13.0% | |
| – | +0.0% | -40.5% | +0.0% | +125.0% | +4.5% | +51.3% | +276.7% | -27.3% | +99.5% | +11.2% | -14.3% | |
| – | -19.9% | +10.4% | +0.0% | +129.5% | -42.7% | +102.2% | +297.7% | -46.5% | +194.1% | -64.6% | +2.1% | |
| – | +1.6% | -41.7% | +0.0% | +129.5% | -42.7% | +102.2% | +371.1% | -31.7% | +129.0% | +12.0% | -17.5% | |
| – | -21.5% | -48.6% | +0.0% | +40.6% | +3,120.4% | -16.8% | +94.2% | -15.5% | -94.8% | -24.6% | +7.2% | |
| – | – | – | – | – | – | +149.6% | -32.2% | -20.2% | +35.3% | -41.0% | -21.3% | |
| – | -14.2% | +7.9% | -19.2% | +13.8% | +24.0% | +76.5% | +257.5% | -39.6% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -30.4% | -42.8% | -67.0% | +8,514.8% | -11.8% | -8.9% | -9.8% | – | – | – | – | |
| – | +19.3% | -50.3% | +0.0% | +1,023.1% | +7.8% | +13.2% | +7.9% | +6.3% | +5.8% | -7.8% | -29.4% | |
| – | +52.1% | +3.9% | +0.0% | +309.5% | -46.8% | +29.2% | +58.9% | +46.0% | +83.2% | -22.5% | -24.5% | |
| – | – | – | – | -99.8% | +1,503.3% | +1,655.7% | -90.7% | +1,313.6% | -94.9% | +121.5% | +62.1% | |
| – | +83.2% | -25.5% | +0.0% | +555.8% | -37.1% | +14.8% | +53.5% | -19.9% | +9.9% | +80.2% | -10.5% | |
| – | – | – | – | +1.8% | +168.0% | -19.6% | -3.7% | -19.8% | – | – | – | |
| – | -10.6% | -36.1% | +0.0% | -12.4% | -28.7% | +122.6% | +894.4% | -47.7% | +176.4% | +26.4% | -9.0% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +11.4% | +3.4% | +11.8% | +30.8% | +125.6% | +23.1% | +124.0% | +29.8% | +4.3% | +44.7% | +30.1% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.